About Bluejay Diagnostics, Inc. - Common Stock (BJDX)
Bluejay Diagnostics, Inc. is a healthcare company focused on the development and commercialization of innovative diagnostic solutions that improve patient care and streamline clinical decision-making. The company leverages advanced technologies to create rapid, cost-effective testing methods for various medical conditions, aiming to enhance diagnostic accuracy and efficiency in both laboratory and point-of-care settings. By prioritizing patient needs and leveraging cutting-edge research, Bluejay is positioned to make significant advancements in the realm of medical diagnostics, ultimately contributing to better health outcomes. Read More
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday's regular session. The company's market cap stands at $60.6 million. Bluejay Diagnostics (NASDAQ:BJDX) shares
Gainers Bluejay Diagnostics (NASDAQ:BJDX) shares moved upwards by 43.0% to $1.43 during Wednesday's pre-market session. The company's market cap stands at $1.0 million. Estrella Immunopharma (NASDAQ:ESLA)
Gainers Bluejay Diagnostics (NASDAQ:BJDX) stock moved upwards by 42.0% to $1.42 during Tuesday's after-market session. American Well (NYSE:AMWL) stock rose 12.76% to $11.75. The market value of their outstanding
In a world where pathogen outbreaks, hospital infections, and foodborne illnesses are becoming increasingly common, TOMI Environmental Solutions (NASDAQ: TOMZ) is stepping forward with a proven, scalable technology addressing one of the world’s most urgent needs— clean, safe, and automated disinfection.
